GET DAILY SIGNALSCoincheck Group (CNCK) Reports -43% Revenue Drop and Net Loss
Key Takeaways
- Coincheck Group reported total revenue of ¥75.5 billion ($480 million) for the second quarter of fiscal 2027, a 43% decline from ¥133.1 billion ($846 million) a year earlier, missing consensus estimates.
- The company swung to a net loss of ¥4.14 billion ($26.3 million), compared with net income of ¥355 million ($2.3 million) in the prior-year quarter.
- Adjusted EBITDA was a loss of ¥4.02 billion ($25.6 million), versus a positive ¥1.49 billion ($9.5 million) a year ago.
- A ¥2.96 billion ($18.8 million) impairment loss tied to the Aplo subsidiary was a key driver of the quarterly loss.
- Marketplace trading volume fell 56% year over year, reflecting weaker crypto asset market conditions across Bitcoin, Ethereum, and XRP.
- More details on CNCK's Major News, Today's Price Move, Price Targets, and Forecasts and Predictions appear on the dedicated pages.
- Explore Trending AI Robots to see how AI-driven trading strategies are positioned across the market.
Earnings Context and Why It Matters
Coincheck Group N.V. (NASDAQ: CNCK) serves as the holding company for Coincheck, Inc., one of Japan's largest regulated cryptocurrency exchanges. As a digital-asset business, its results tie closely to crypto trading activity and asset prices, so quarterly earnings provide a useful gauge of the broader crypto market cycle. This report comes during a period of falling cryptocurrency prices that directly pressure marketplace trading volumes and customer assets. For investors, the quarter offers insight into whether Coincheck can offset shrinking trading revenue through institutional services, custody, staking, and asset management—the diversification path management has followed via acquisitions such as 3iQ and Aplo. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Breaking Down the Reported Results
Coincheck reported financial results for the second quarter of its fiscal year ending March 31, 2027, covering the three months ended September 30, 2026. Total revenue declined 43% to ¥75.5 billion ($480 million), down from ¥133.1 billion ($846 million) in the second quarter of fiscal 2026 and below consensus estimates of roughly $627 million to $645 million.
The company swung to a net loss of ¥4.14 billion ($26.3 million), compared with net income of ¥355 million ($2.3 million) a year earlier. The decline was driven primarily by an impairment loss of ¥2.96 billion ($18.8 million) related to the Aplo subsidiary, lower marketplace trading volume, and higher selling, general, and administrative (SG&A) expenses, partially offset by a net tax benefit.
Adjusted EBITDA was a loss of ¥4.02 billion ($25.6 million), versus a positive ¥1.49 billion ($9.5 million) in the prior-year quarter. SG&A expenses rose to ¥4.19 billion ($26.6 million) from ¥3.37 billion ($21.4 million), reflecting higher headcount and costs from the 3iQ and Aplo acquisitions.
Operationally, verified accounts increased 18% to 2.87 million, while customer assets declined 26% to ¥876.9 billion ($5.6 billion) amid falling crypto prices. Marketplace trading volume dropped 56% to ¥41.5 billion ($264 million). Assets under management (AUM) at 3iQ stood at ¥148.8 billion ($946 million). The company ended the quarter with cash and cash equivalents of ¥14 billion ($89 million). From what I see, these figures highlight the direct impact of softer crypto markets on the core business.
Market Reaction and Investor Sentiment
The results fell short of Wall Street expectations, with revenue of $480 million missing consensus by a wide margin and the company reporting a net loss where analysts had expected a narrower shortfall. The disappointing quarter reflects a challenging crypto pricing environment, as declines in Bitcoin, Ethereum, and XRP compressed both trading volumes and customer asset balances. The sizable Aplo-related impairment added a one-time, non-cash charge that further pressured the bottom line. Sentiment around the name remains cautious, with the company's stock having traded near the lower end of its 52-week range ahead of the release. Investors are likely to focus on whether the diversification into institutional and asset-management revenue can stabilize results through the downturn.
Forward Outlook and Key Factors to Monitor
Following this quarter, investors should watch several factors that could shape Coincheck's trajectory. First, crypto asset prices and industry trading volumes will remain the dominant swing factors, given the company's heavy reliance on marketplace trading revenue. A sustained recovery in Bitcoin, Ethereum, and XRP prices would likely support a rebound in trading activity and customer asset values.
Second, the pace of diversification matters. Management has emphasized institutional services, custody, staking, and asset management through the 3iQ and Aplo acquisitions. The growth of these higher-margin, fee-based revenue streams will be important in reducing dependence on volatile trading volumes. I’m watching this closely as the integration progresses.
Third, cost discipline is worth monitoring. SG&A expenses rose on higher headcount and acquisition-related costs, and the Aplo impairment signals integration risks. Investors will want to see whether expense growth moderates and whether further impairments are avoided.
Finally, Japan's evolving regulatory landscape—including clarified institutional custody guidelines—could unlock new opportunities, while planned initiatives such as loyalty-point crypto trading and potential ETF products represent longer-term catalysts. As always, these are known themes to watch, not predictions, and outcomes will depend on broader market conditions.
Enhancing Research with Tickeron Tools
In my research process, Tickeron’s AI Screener has become a regular part of reviewing names like CNCK. It lets me apply filters for technical patterns, fundamentals, and AI signals across thousands of stocks and ETFs, helping surface comparisons and ideas more efficiently than manual checks. This approach adds a systematic layer when evaluating how individual companies fit within sector trends.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CNCK's RSI Oscillator recovers from oversold territory
The RSI Oscillator for CNCK moved out of oversold territory on October 27, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 20 similar instances when the indicator left oversold territory. In 13 of the 20 cases the stock moved higher. This puts the odds of a move higher at 65%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 30 of 59 cases where CNCK's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 51%.
The Moving Average Convergence Divergence (MACD) for CNCK just turned positive on October 15, 2026. Looking at past instances where CNCK's MACD turned positive, the stock continued to rise in 20 of 53 cases over the following month. The odds of a continued upward trend are 38%.
Following a +7.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNCK advanced for three days, in 81 of 130 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CNCK as a result. In 35 of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 36%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNCK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
The Aroon Indicator for CNCK entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.008) is normal, around the industry mean (3.120). P/E Ratio (-0.127) is within average values for comparable stocks, (6.734). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (8.976) among similar stocks. P/S Ratio (0.083) is also within normal values, averaging (16.899).
The Tickeron SMR rating for this company is 60 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 80 (best 1 - 100 worst), indicating slightly worse than average price growth. CNCK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNCK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry InvestmentBanksBrokers
Advertisement